Cochlear Sustainability Profile
Cochlear Limited, commonly referred to as Cochlear, is a global leader in implantable hearing solutions, headquartered in Sydney, Australia. Founded in 1981, the company has pioneered advancements in the field of audiology, particularly with its innovative cochlear implants and bone conduction devices. Cochlear operates in key markets across Europe, North America, and Asia, providing life-changing hearing solutions to individuals with hearing loss. Its flagship products, including the Nucleus® cochlear implant system and the Baha® bone conduction system, are distinguished by their cutting-edge technology and commitment to improving user experience. With a strong market position, Cochlear has received numerous accolades for its contributions to hearing health, solidifying its reputation as a trusted name in the industry. The company continues to lead the way in research and development, ensuring that it remains at the forefront of hearing innovation.
DitchCarbon Score
How does Cochlear's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cochlear's score of 48 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cochlear's reported carbon emissions
In 2024, Cochlear Limited reported total carbon emissions of approximately 6,036,000 kg CO2e, comprising 856,000 kg CO2e from Scope 1, 2,183,000 kg CO2e from Scope 2, and 2,997,000 kg CO2e from Scope 3 emissions. The previous year, 2023, saw total emissions of about 6,326,000 kg CO2e, with Scope 1 emissions at 916,000 kg CO2e, Scope 2 at 2,401,000 kg CO2e, and Scope 3 at 3,009,000 kg CO2e. Cochlear has set ambitious climate commitments, aiming for a 25% reduction in absolute Scope 1 and Scope 2 emissions by 2025, and a 50% reduction in business flight-related emissions (Scope 3) by the same year. Furthermore, the company is targeting net-zero emissions in its operations (Scope 1 and 2) by 2030. These initiatives reflect Cochlear's commitment to sustainability and reducing its carbon footprint, aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 728,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 13,537,000 | 0,000,000 | 0,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
How Carbon Intensive is Cochlear's Industry?
How Carbon Intensive is Cochlear's Location?
Cochlear's Scope 3 Categories Breakdown
Cochlear's Scope 3 emissions, which decreased by 0% last year and decreased by approximately 84% since 2019, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 50% of total emissions under the GHG Protocol, with "Business Travel" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
Cochlear's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cochlear has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Siemens Healthineers AG
Starkey Hearing Technologies, Inc.
Ws Audiology
Boston Scientific
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.